Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
The current price of BWAY.BOATS is $12.87 USD — it has increased by +0.08% in the past 24 hours. Watch Brainsway stock price performance more closely on the chart.
What is Brainsway stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Brainsway stocks are traded under the ticker BWAY.BOATS.
When did Brainsway complete a stock split?▼
The last stock split for Brainsway was on March 03, 2026 with a ratio of 2:1.